Total Funding
88
18
Total FundingSeries B raised
Growth Score 88 in past quarter
-5 pts
Heat Score 18 in past quarter
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
20733
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
- Leonardo Faoro: Chief Medical OfficerPast Role: Quanta Therapeutics, Chief Medical Officer
- Andrew S. Chi: Chief Medical Officer
About the Company
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.